35 completed, 7 terminated, 2 recruiting, 2 withdrawn. 13 Phase 4, 8 Phase 2, 7 Not applicable, 7 Phase 3, 5 Phase 1.
Follow Innovaderm Research Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy Abrocitinib 200 mg, Abrocitinib 100 mg, Placebo - Chronic Hand Eczema | Phase 2 | Completed | Innovaderm Research Inc. | 82 | 2024-05-31 | 2026-02-03 |
| Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus Ruxolitinib 1.5% cream, Application without occlusion in Area 1, Application under occlusion at night in Area 2 - Discoid Lupus Erythematosus | Phase 2 | Recruiting | Innovaderm Research Inc. | 20 | 2024-04-19 | 2025-03-24 |
| Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers Blood samples collection, Oral samples collection, Hair samples collection - Acne, Atopic Dermatitis | Recruiting | Innovaderm Research Inc. | 500 | 2023-10-17 | 2026-03-30 | |
| Study to Assess the Reliability of PASI Scoring Using Digital-Based Images In-Person and Remote Disease Assessment - Plaque Psoriasis | Completed | Innovaderm Research Inc. | 34 | 2023-06-02 | 2025-09-12 | |
| Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitis Triamcinolone Acetonide (Aristocort® C), Vehicle - Atopic Dermatitis | Phase 4 | Completed | Innovaderm Research Inc. | 20 | 2023-05-09 | 2025-03-26 |
| A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis BMX-010, Placebo - Atopic Dermatitis | Phase 2 | Terminated | BioMimetix JV, LLC | 103 | 2023-01-08 | 2024-04-18 |
| Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis Bimekizumab - Psoriasis Vulgaris, Active Psoriatic Arthritis | Phase 4 | Withdrawn | Innovaderm Research Inc. | 2023-01-01 | 2023-03-15 | |
| Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab Abrocitinib - Atopic Dermatitis | Phase 4 | Completed | Innovaderm Research Inc. | 24 | 2022-11-25 | 2025-03-28 |
| A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis FRTX-02 Capsule, Placebo - Atopic Dermatitis Eczema | Phase 1 | Terminated | Fresh Tracks Therapeutics, Inc. | 89 | 2022-05-16 | 2023-08-24 |
| Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis NDI-034858 study drug, Placebo - Moderate to Severe Plaque Psoriasis | Phase 2 | Completed | Takeda | 259 | 2021-08-11 | 2023-09-28 |
| TH1902 in Patients With Advanced Solid Tumors TH1902 - Solid Tumor, TNBC - Triple-Negative Breast Cancer | Phase 1 | Active not recruiting | Theratechnologies | 70 | 2021-03-04 | 2025-04-15 |
| Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis Crisaborole 2%, Placebo ointment - Dermatitis, Atopic | Phase 4 | Completed | Innovaderm Research Inc. | 31 | 2019-05-21 | 2021-08-24 |
| Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum vilobelimab - Pyoderma Gangrenosum | Phase 2 | Completed | InflaRx GmbH | 19 | 2019-05-16 | 2023-09-14 |
| Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics Profiling Microneedle Device - Psoriasis Vulgaris | Completed | Janssen Research & Development, LLC | 11 | 2019-03-15 | 2019-12-13 | |
| A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis ESR-114, Placebo - Psoriatic Plaque | Phase 1 / Phase 2 | Completed | Escalier Biosciences B.V. | 104 | 2018-08-09 | 2020-07-29 |
| Characterization of the Molecular Mechanisms Involved in Delayed-Type Hypersensitivity Reactions to House Dust Mite, Diphencyprone, Nickel, and Tuberculin Purified Protein Derivative in Healthy Volunteers Prednisone, Placebo - Delayed Type Hypersensitivity | Not applicable | Completed | Innovaderm Research Inc. | 54 | 2018-07-26 | 2020-07-17 |
| A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects GSK2894512 1% CREAM, GSK2894512 MATCHING VEHICLE CREAM - Psoriasis | Phase 1 | Withdrawn | GlaxoSmithKline | 2017-12-14 | 2017-11-29 | |
| Development of a Method to Measure mRNA Levels in Skin Samples Skin squame collection, Tape strip collection, Tape strip and skin biopsy collection - Healthy, Atopic Dermatitis Eczema | Not applicable | Completed | Innovaderm Research Inc. | 61 | 2017-05-11 | 2020-09-04 |
| Trial on Vascular Inflammation in Atopic Dermatitis FDG-PET Scan, MDCT, biopsy and blood collection - Atopic Dermatitis, Vascular Inflammation | Completed | Innovaderm Research Inc. | 57 | 2017-01-01 | 2018-12-19 | |
| Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy Varicella Zoster Vaccine, Placebo - Psoriasis | Phase 4 | Terminated | Innovaderm Research Inc. | 3 | 2016-06-01 | 2017-07-02 |
Showing 20 of 47. Sign in to see all of them.
Psoriasis (13) · Dermatitis, Atopic (11) · Coronary Artery Disease (4) · Eczema (4) · Acne Vulgaris (3) · Arthritis, Psoriatic (2) · Hypersensitivity, Delayed (2) · Arthritis, Rheumatoid (1) · Asthma (1) · Carcinoma, Ovarian Epithelial (1) · Crohn Disease (1) · Dermatitis (1) · Dermatitis, Allergic Contact (1) · Endometrial Neoplasms (1) · Food Hypersensitivity (1)
Sodium Chloride (6) · Adalimumab (5) · Etanercept (4) · abrocitinib (2) · 3-lauroyl-glycero-1-phosphate (1) · 4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol (1) · Acitretin (1) · Antioxidants (1) · Ascorbic Acid (1) · Benzoyl Peroxide (1) · Biopsy (1) · Botulinum Toxins, Type A (1) · Capsule Endoscopy (1) · Citric Acid (1) · Denosumab (1)
Canada (44) · United States (8) · Poland (2)
Robert Bissonnette, MD (22) · Robert Bissonnette, MD, FRCPC (9) · Allison Luo, MD (1) · Boulos Haraoui, MD (1) · Catherine Maari, MD, FRCPC (1) · Funda Meric-Burnstam, MD (1) · Jean-Claude Tardif, MD (1) · Jean-Claude Tardif, MD, FRCPC (1) · Jerry Tan, MD, FRCPC (1) · Lyn Guenther, MD, FRCPC (1) · Maggie Wang, MD (1) · Prof. Niels C. Riedemann, M.D., Ph.D. (1)
PMID 21797805, PMID 23204039, PMID 28286061, PMID 32709423, PMID 39167366, PMID 42143206